1. A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers. (29th March 2019) Authors: Finnema, Sjoerd J.; Rossano, Samantha; Naganawa, Mika; Henry, Shannan; Gao, Hong; Pracitto, Richard; Maguire, Ralph P.; Mercier, Joël; Kervyn, Sophie; Nicolas, Jean‐Marie; Klitgaard, Henrik; DeBruyn, Steven; Otoul, Christian; Martin, Paul; Muglia, Pierandrea; Matuskey, David; Nabulsi, Nabeel B.; ... Journal: Epilepsia Issue: Volume 60:issue 5(2019) Page Start: 958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in epilepsy treatment: lacosamide pharmacokinetic profile. (28th August 2014) Authors: Cawello, Willi; Stockis, Armel; Andreas, Jens‐Otto; Dimova, Svetlana Journal: Annals of the New York Academy of Sciences Issue: Volume 1329(2014) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of a white matter reference region for 11C-UCB-J PET quantification. Issue 9 (September 2020) Authors: Rossano, Samantha; Toyonaga, Takuya; Finnema, Sjoerd J; Naganawa, Mika; Lu, Yihuan; Nabulsi, Nabeel; Ropchan, Jim; De Bruyn, Steven; Otoul, Christian; Stockis, Armel; Nicolas, Jean-Marie; Martin, Paul; Mercier, Joel; Huang, Yiyun; Maguire, R Paul; Carson, Richard E Journal: Journal of cerebral blood flow & metabolism Issue: Volume 40:Issue 9(2020) Page Start: 1890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus. (26th June 2016) Authors: Stockis, Armel; Hartstra, Jan; Mollet, Muriel; Hadi, Salah Journal: Epilepsia Issue: Volume 57:issue 8(2016) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bioavailability, safety and tolerability of intravenous brivaracetam in healthy Japanese participants. (1st February 2022) Authors: Yamamoto, Junichi; Ikeda, Kaori; Stockis, Armel Journal: Xenobiotica Issue: Volume 52:Number 2(2022) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brivaracetam Disposition in Mild to Severe Hepatic Impairment. (3rd May 2013) Authors: Stockis, Armel; Sargentini‐Maier, Maria Laura; Horsmans, Yves Journal: Journal of clinical pharmacology Issue: Volume 53:Number 6(2013:Jun.) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Brivaracetam Population Pharmacokinetics and Exposure‐Response Modeling in Adult Subjects With Partial‐Onset Seizures. (7th June 2016) Authors: Schoemaker, Rik; Wade, Janet R.; Stockis, Armel Journal: Journal of clinical pharmacology Issue: Volume 56:Number 12(2016) Page Start: 1591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action. (10th December 2015) Authors: Nicolas, Jean‐Marie; Hannestad, Jonas; Holden, Daniel; Kervyn, Sophie; Nabulsi, Nabeel; Tytgat, Dominique; Huang, Yiyun; Chanteux, Hugues; Staelens, Ludovicus; Matagne, Alain; Mathy, François‐Xavier; Mercier, Joël; Stockis, Armel; Carson, Richard E.; Klitgaard, Henrik Journal: Epilepsia Issue: Volume 57:issue 2(2016) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical pharmacology of levetiracetam for the treatment of epilepsy. Issue 4 (July 2009) Authors: Stockis, Armel; Lu, Sarah; Tonner, Françoise; Otoul, Christian Journal: Expert review of clinical pharmacology Issue: Volume 2:Issue 4(2009) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women. (10th October 2013) Authors: Stockis, Armel; Rolan, Paul Journal: Journal of clinical pharmacology Issue: Volume 53:Number 12(2013:Dec.) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗